12Feb/13

Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System … – PR Newswire (press release)

Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System
PR Newswire (press release)
12, 2013 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the Promus PREMIER™ Everolimus-Eluting Platinum Chromium Coronary Stent System, the company’s next-generation durable polymer drug-eluting